aspirin has been researched along with Hepatitis B Virus Infection in 11 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin use may have chemo-preventive effect on recurrence of hepatitis B virus-related HCC after curative resection." | 7.96 | Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection. ( Chao, Y; Chau, GY; Hou, MC; Huang, YH; Huo, TI; Lee, IC; Lee, MH; Lin, HC; Su, CW; Yeh, YC; Young, SH, 2020) |
| "Aspirin use may have chemo-preventive effect on recurrence of hepatitis B virus-related HCC after curative resection." | 3.96 | Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection. ( Chao, Y; Chau, GY; Hou, MC; Huang, YH; Huo, TI; Lee, IC; Lee, MH; Lin, HC; Su, CW; Yeh, YC; Young, SH, 2020) |
| " While the patient was on aspirin therapy, her symptoms improved dramatically and eventually resolved as she showed evidence, through laboratory findings, of an anicteric hepatitis B infection." | 3.66 | Hepatitis B presenting with tenosynovitis. ( Eversmeyer, WH; Greenberg, RN; Sanders, CV, 1979) |
| "For the prevention of oesophageal cancer, antitumour-B and retinamide have provided hopeful results, although it is not clear that these findings can be extrapolated from the study populations in Asia to western countries." | 2.43 | Chemoprevention in gastrointestinal cancers: current status. ( Baron, JA; Grau, MV; Rees, JR, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, J | 1 |
| Huang, R | 1 |
| Zhang, Z | 1 |
| Wang, J | 1 |
| Zhang, S | 1 |
| Wu, C | 1 |
| Klose, G | 1 |
| Fox, RK | 1 |
| Taddei, TH | 1 |
| Kaplan, DE | 1 |
| Young, SH | 1 |
| Chau, GY | 1 |
| Lee, IC | 1 |
| Yeh, YC | 1 |
| Chao, Y | 1 |
| Huo, TI | 1 |
| Su, CW | 1 |
| Lin, HC | 1 |
| Hou, MC | 1 |
| Lee, MH | 1 |
| Huang, YH | 1 |
| Ishibashi, M | 1 |
| Miyamoto, J | 1 |
| Nagasaka, T | 1 |
| Chen, KR | 1 |
| Levy, IG | 1 |
| Pim, CP | 1 |
| Wong, F | 1 |
| Grau, MV | 1 |
| Rees, JR | 1 |
| Baron, JA | 1 |
| De Vita, C | 1 |
| Greenberg, RN | 1 |
| Eversmeyer, WH | 1 |
| Sanders, CV | 1 |
3 reviews available for aspirin and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Topics: Aspirin; Carcinoma, Hepatocellular; Hepatitis B; Humans; Liver Neoplasms | 2020 |
Liver and kidney diseases.
Topics: Acetaminophen; Anemia, Sickle Cell; Animals; Aspirin; Cholestasis; Cysts; Glomerulonephritis, IGA; G | 2002 |
Chemoprevention in gastrointestinal cancers: current status.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Hepatocellular; Clinical Trials as Topi | 2006 |
8 other studies available for aspirin and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B.
Topics: Aspirin; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Li | 2023 |
Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B.
Topics: Aspirin; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Li | 2023 |
Aspirin Use and Risk of Hepatocellular Carcinoma in Hepatitis B.
Topics: Aspirin; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B, Chronic; Humans; Liver Neoplasms | 2019 |
Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
Topics: Aged; alpha-Fetoproteins; Antiviral Agents; Aspirin; Carcinoma, Hepatocellular; Female; Hepatectomy; | 2020 |
Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
Topics: Administration, Oral; Adult; Alprostadil; Aspirin; Biopsy; Carrier State; Combined Modality Therapy; | 2009 |
An aspirin a day: the allure (and distraction) of chemoprevention.
Topics: Alcohol Drinking; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin | 2012 |
[Problems of the operated patient and suggestions for their treatment].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Anxiety Disorders; Arrhythmias, Cardiac; As | 1982 |
Hepatitis B presenting with tenosynovitis.
Topics: Adult; Aspirin; Female; Hepatitis B; Humans; Tenosynovitis | 1979 |